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The adenosine A1 receptor (A1R) is a G protein-coupled receptor (GPCR) for adenosine, a ubiquitous
neuromodulator, and thus regulates neuronal excitability, as well as arousal and sensitivity to pain. In
addition, we have previously described a new mode of action for A1R: in cerebellar Purkinje cells, its
activation attenuates neuronal responses to glutamate, as mediated by the type-1 metabotropic gluta-
mate receptor (mGluR1). mGluR1 is also a GPCR, and elicits such responses as long-term depression of
the postsynaptic response to glutamate, a cellular basis for cerebellar motor learning. Here, we explore in
greater detail the interaction between A1R and mGluR1 using non-neuronal cells. Co-
immunoprecipitation and F€orster resonance energy transfer (FRET) analysis reveal that A1R and
mGluR1 form a complex. Furthermore, we found that mGluR1 activation inhibits A1R signaling, as
measured by changes in intracellular cAMP. These ﬁndings demonstrate that A1R and mGluR1 have the
intrinsic ability to form a heteromeric complex and mutually modulate signaling. This interaction may
represent a new form of intriguing GPCR-mediated cellular responses.
© 2015 The Authors. Production and hosting by Elsevier B.V. on behalf of Japanese Pharmacological
Society. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/
licenses/by-nc-nd/4.0/).1. Introduction
Adenosine is an important cofactor in biochemical processes
such as energy transfer and signal transduction. It is also a neuro-
modulator believed to regulate pain, protect neurons against hyp-
oxia and ischemia, suppress arousal, and promote sleep (1, 2). To
date, four subtypes of GPCRs have been identiﬁed for adenosine,
namely A1, A2A, A2B, and A3. Of these, the A1 receptor (A1R) has
the highest afﬁnity for adenosine, at approximately 70 nM, and can
thus respond to basal levels, which is between 20 and 400 nM in
the extracellular ﬂuid of some regions of the brain (3, 4). Indeed,
many regions of neural tissue express A1R and respond to A1R-
selective agonists (5). Finally, A1R is coupled to Gi/Go, a G protein
sensitive to pertussis toxin (6) and inhibits adenylyl cyclase and
potentiates phospholipase C (7).
Many reports suggest that multiple GPCRs form heteromeric
complexes and cooperatively trigger atypical signaling that cannotfax: þ81 (0) 3 5802 0419.
ubo).
rmacological Society.
g by Elsevier B.V. on behalf of Japa
d/4.0/).be initiated by individual GPCRs on their own (8, 9). Indeed, pre-
vious studies suggest that A1R activation also modulates cellular
responses that depend on mGluR1 (10e12). mGluR1 induces syn-
aptic plasticity including cerebellar long-term depression (LTD) at
synapses between cerebellar parallel ﬁbers and Purkinje cells. In
turn, cerebellar LTD is crucial for cerebellar motor learning (13, 14).
Recently, we showed that A1R activation attenuates LTD in
cultured Purkinje cells, possibly by complex formation between
A1R and mGluR1 (15). To explore the functional properties of the
mGluR1-A1R heteromeric complex, we now investigate whether
mGluR1 could trigger a reciprocal effect on A1R-dependent path-
ways, using intracellular cAMP as amarker. The results indicate that
these receptors mutually modulate each other by direct interaction.
These ﬁndings indicate a new mechanism of cooperation between
neuronal GPCRs to elicit atypical and intriguing cellular responses.
2. Materials and methods
2.1. Cell lines
To establish cell lines stably expressing both mGluR1 and A1R,
we used a Tet-inducible system, because GPCR expression fromnese Pharmacological Society. This is an open access article under the CC BY-NC-ND
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Rex system (Invitrogen, CA, USA) to stably integrate mGluR1 into a
Flp recombination site in the genome. A stable cell line was thus
obtained, in which expression of mGluR1 could be induced with
doxycycline (Dox). We then used Jump-In Fast system (Invitrogen)
to integrate A1R into several genomic hotspots using PhiC31 inte-
grase. As resulting clones express A1R at variable levels, it was
possible to select a clone with comparable expression of mGluR1
and A1R.
Details follow. To construct an expression vector appropriate for
integration by PhiC31, PhiC31 attB was ampliﬁed and inserted into
the MfeI site in pcDNA3.1(þ). To obtain Tet-inducible expression in
T-Rex cell lines, the CMV promoter in pcDNA3.1 was replaced with
the CMV promoter derived from pcDNA5/FRT/TO, which includes
two tandem tet operators. Finally, Gateway conversion cassette b
was inserted into pcDNA3.1(þ) at the EcoRV site to generate
pcDNA3/TO-GW-phiC31. Rat A1R and mGluR1cDNAs were subcl-
oned from the Gateway entry vector into pcDNA3/TO-GW-phiC31
and pcDNA5/FRT/TO-GW, respectively, using the LR reaction.
Flp-In T-Rex 293 cells were grown in Dulbecco's modiﬁed Ea-
gle's medium supplemented with 10% fetal bovine serum (FBS),
blasticidin, and zeocin. Cells were then transfected with pcDNA5/
FRT/TO-mGluR1 and pOG44, and stably transformed clones were
selected on blasticidin and hygromycin. Next, a selected clone,
termed HEK293m, was transfected with pcDNA3/TO-A1R-phiC31
and pJTI PhiC31 Int. Stable transformants were selected on G418,
blasticidin and hygromycin. Thus, several clones with inducible
expression of A1R and mGluR1 were obtained. These cells, termed
HEK293am, were treated with 2 mM Dox to induce expression, and
analyzed 16e24 h thereafter, at which point receptors have not yet
been overexpressed.
2.2. Antibodies
We used commercially available mouse antibodies against
mGluR1 (BD Biosciences, San Jose, CA, USA) and rabbit antibodies
against Naþ/Kþ-ATPase (NAKA) (Abcam, Cambridge, MA, USA), as
well as secondary antibodies against mouse or rabbit IgG that are
highly cross-adsorbed and conjugated with Alexa Fluor (AF) 488,
594 or 647 (Molecular Probes, Eugene, OR, USA). In addition, anti-
bodies raised in rabbits against synthetic peptides corresponding to
amino acids 1116e1130 of rat mGluR1a and amino acids 309e326
of rat A1R, were used. Both peptides are in the intracellular domain
(15).
2.3. Co-immunoprecipitation
mGluR1 and A1R were immunoprecipitated as described else-
where (15). Brieﬂy, HEK293 cells were lysed at 4 C for 60 min in
RIPA buffer consisting of 1% Nonidet P-40, 0.5% sodium deoxy-
cholate, 0.1% SDS, 25 mM TriseHCl pH 7.5, 137 mM NaCl, 3 mM KCl
and protease inhibitor cocktail (Complete, Roche Diagnostics,
Mannheim, Germany). Cell lysates were incubated at 4 C for at
least 12 h with protein A magnetic beads (Invitrogen) containing
5e12 mg antibodies against mGluR1 or A1R. Immunoprecipitates
were washed four times with cold RIPA buffer, and bound proteins
were eluted at room temperature for 1 h with 2  lithium dode-
cylsulfate sample buffer with dithiothreitol. Eluates were electro-
phoresed and immunoblotted as described elsewhere (16).
2.4. Immunoﬂuorescence
HEK293am cells in glass-bottom dishes were ﬁxed at 4 C for
30 min with 0.1 M sodium phosphate buffer containing 4% para-
formaldehyde. Samples were then rinsed with phosphate-bufferedsaline (PBS), and then incubated at room temperature for 30 min in
PBS supplemented with 0.1% Triton X-100 and 5% FBS (17). Cells
were then probed at 4 C overnight with 1 mg/mL primary antibody
against mGluR1 or A1R, and subsequently stained at room tem-
perature for 2.5 h with 5 mg/mL ﬂuorescently labeled secondary
antibodies. Cells were examined using a confocal laser microscope
(Leica Microsystems, Wetzlar, Germany).
2.5. FRET
HEK293am cells were doubly probed with a combination of
mouse antibodies against mGluR1, and either rabbit anti-A1R,
anti-NAKA, or control IgG. To exclude the possibility that non-
speciﬁc interactions caused FRET, we used the antibody to
NAKA, an endogenous plasma membrane marker, as a second
control. After staining with ﬂuorescently labeled secondary anti-
bodies, a Leica SP5/TCS confocal laser-scanning microscope (Leica
Microsystems) was used to measure FRET. Donor labels, AF594,
were excited with a 543 nm Green HeNe laser, and emission was
collected around 620 nm. A 633 nm Red HeNe laser was used to
excite the acceptor labels AF647, emission from which was
collected around 680 nm. For acceptor photobleaching, 20e50
scan cycles with the 633 nm laser at maximum intensity was used.
Using Leica Application Suite (Leica), FRET efﬁciency (FRETeff) was
calculated (18, 19) as
FRETeff ¼ (DpostDpre)/Dpost
where Dpre and Dpost are ﬂuorescence intensity of the FRET donor
before and after photobleaching, respectively.
2.6. LANCE cAMP assay
Intracellular cAMP was measured using LANCE™ cAMP
competitive immunoassay (PerkinElmer Inc., Boston, MA, USA),
following manufacturer instructions. Brieﬂy, HEK293am cells were
treated with 2 mM Dox for 16e24 h, and suspended at a density of
~400 cells/mL in Hank's balanced salt solution containing 5 mM
HEPES, 0.1% bovine serum albumin, and 0.5 mM iso-
butylmethylxanthine (IBMX, SigmaeAldrich, MI, USA). Suspensions
were then supplemented with forskolin (Nacalai, Kyoto, Japan),
()-N6-(2-Phenylisopropyl)adenosine (R-PIA, SigmaeAldrich),
(RS)-3,5-Dihydroxyphenylglycine (DHPG, Tocris, Bristol, UK), 7-
(Hydroxyimino)cyclopropa[b]chromen-1a-carboxylate ethyl ester
(CPCCOEt, Tocris), and/or substance P (SP, Sigma) at concentrations
as indicated. To inhibit Gi/Go, HEK293am cells were pretreated with
pertussis toxin (PTX, Calbiochem, San Diego, CA, USA) for > 12 h
before analysis. Suspensions were then incubated for 30 min at
room temperature with AF647-conjugated antibodies against
cAMP. Subsequently, cells were incubated with LANCE™ detection
buffer containing the Europium-labeled streptavidin, the biotin-
cAMP and Triton X-100 for 60 min at room temperature. Time-
resolved (TR)-FRET was measured using an EnVision multilabel
plate reader (PerkinElmer).
3. Results
3.1. A1R and mGluR1 form a complex
To evaluate in detail the physiological response to the complex
formed by A1R and mGluR1, we generated HEK293am cells, which
are HEK293 cells with Tet-inducible expression of A1R and mGluR1
(Fig. 1). After treatment with 2 mM Dox for 16 h, expression of both
receptors was detectable in all the tested clones (Fig. 1A, B). The
clone marked (d) in Fig. 1A was selected for subsequent analyses,
Fig. 1. Complex formation between A1R and mGluR1 in HEK293am cells. (A, B)
Immunoblotting analysis of doxycycline (Dox)-induced expression of A1R and mGluR1
in HEK293am cells. HEK293am clones were treated with 2 mM Dox or vehicle for 18 h,
and extracts were analyzed with antibodies against mGluR1 (A) and A1R (B). (C)
Immunoﬂuorescence staining of HEK293am cells with anti-mGluR1 and anti-A1R in-
dicates that the receptors are colocalized. Scale bar, 10 mm. (D) Co-
immunoprecipitation of mGluR1 with A1R. Lysates from HEK293am cells were
immunoprecipitated with rabbit anti-A1R or control IgG, and precipitates were
immunoblotted with mouse antibody against mGluR1. Monomeric and dimeric
mGluR1 were detected (arrows). (E) A1R was detected (arrowhead) in immunopre-
cipitates obtained with anti-mGluR1.
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manner (Fig. 3). Immunoﬂuorescent staining demonstrated inti-
mate colocalization of A1R and mGluR1 (Fig. 1C). Further, we
believe the complex forms at the plasma membrane, because the
distribution of mGluR1 overlapswith NAKA, amarker of the plasma
membrane (Fig. S1). A1R-mGluR1 colocalization was not due to
non-speciﬁc aggregation, because such aggregation was not
observed by total internal reﬂection ﬂuorescence microscopy (data
not shown).In addition, we performed co-immunoprecipitation experi-
ments with HEK293am cells treated with Dox for 18e24 h. In
fractions precipitated with anti-A1R, monomer and dimeric
mGluR1 were detected at the corresponding molecular weights of
~150 and ~300 kDa, respectively (Fig. 1D). Corollarily, A1R was
detected in immunoprecipitates obtained with anti-mGluR1
(Fig. 1E). These results suggest that A1R and mGluR1 form a com-
plex in HEK293am cells.
3.2. A1R and mGluR1 physically associate in situ
We investigated whether A1R andmGluR1 interacted physically
in situ, using FRET. Fixed and permeabilized HEK293am cells were
doubly stained with mouse antibodies against mGluR1, and with
either rabbit anti-A1R, anti-NAKA, or non-immunized control IgG,
and then probed with highly cross-adsorbed secondary antibodies
for IgG conjugated with AF594 (anti-mouse) and AF647 (anti-rab-
bit) (Fig. S1).
In comparison to cells probed with mGluR1 and control IgG,
ﬂuorescence from AF594 was reduced in cells probed with an-
tibodies against mGluR1 and A1R, while ﬂuorescence from AF647
was enhanced (Fig. 2A). In addition, ﬂuorescence from the donor
increased after photobleaching the acceptor in cells stained with
antibodies against GPCRs (Fig. 2B), but not in cells co-stained
with mGluR1 and control IgG (Fig. 2C). To exclude the possibil-
ity that non-speciﬁc interaction caused FRET, we used NAKA, an
endogenous plasma membrane marker, as a second control. In
the HEK293am cells co-stained with NAKA and mGlu1R, FRET
remained below the signal obtained in cells probed with mGlu1R
and A1R (Fig. 2D,E). These results provide strong evidence that
A1R and mGluR1 physically associate in situ at the plasma
membrane.
3.3. mGluR1 and A1R crosstalk
We examined whether and how mGluR1 may modulate A1R
signaling, based on the ability of A1R to suppress cAMP production
when stimulated. To enable the measurement of the A1R-mediated
reduction in the intracellular cAMP ([cAMP]i), the basal [cAMP]i
was raised by a treatment with the adenylyl cyclase activator for-
skolin and IBMX. We measured the [cAMP]i using the LANCE cAMP
384 kits. The LANCE signal, based on TR-FRET, is inversely propor-
tional to [cAMP]i (Fig. S2).
Forskolin decreased TR-FRET in a dose-dependent manner
(Fig. 3A). Treatment with forskolin and 100 nM R-PIA, a selective
A1R agonist, shifts the TR-FRET curve to the right, consistent with
suppression of adenylyl cyclase activity by A1R. To test the
involvement of Gi/Go, the primary G protein coupled to A1R, we
measured [cAMP]i in HEK293am cells pretreated for > 16 h with
500 ng/mL pertussis toxin (PTX), an inhibitor of Gi/Go. The toxin
reversed the effect of R-PIA on [cAMP]i, suggesting that Gi/Go is
involved (Fig. 3B). Furthermore, the effect of R-PIA was also
reversed by the A1R antagonist DPCPX (Fig. 3C). These experiments
indicate that HEK293am cells are suitable models in which to
analyze A1R signaling.
We investigated the interaction between mGluR1 and A1R by
measuring A1R-dependent changes in intracellular cAMP. The
mGluR1 agonist DHPG inhibited R-PIA action (Fig. 4A) in a dose-
dependent manner (Fig. 5A), although DHPG alone did not affect
basal [cAMP]i or forskolin action (Fig. 5B). In turn, 50 mM CPCCOEt,
an mGluR1 antagonist, abolished the effect of DHPG (Fig. 4B).
However, CPCCOEt on its own did not affect the basal [cAMP]i or
reverse the effects of forskolin (Fig. 4C). These results strongly
suggest that mGluR1 activation attenuates A1R signaling. Using
neurokinin-1 receptor (NK1R) coupled to a Gq, we further
Fig. 2. Physical interaction between A1R and mGluR1 in HEK293am cells. HEK293am cells were probed with mouse anti-mGluR1 (mGluR1-AF594), and rabbit anti-A1R (A1R-
AF647), anti-Naþ/Kþ-ATPase (NAKA-AF647) or control IgG (Ctrl-AF647). (A) Fluorescent spectrum of double labeling of mGluR1-AF594 with A1R-AF647 (ﬁlled circle) or Ctrl-AF647
(open square) excited at 543 nm. Data points are mean ± SEM. (B, C) Intensities of AF594 immunolabeled mGluR1 (mGluR1-AF594) ﬂuorescence before and after a photobleaching
of AF 647. AF594 was excited at 543 nm and emission detected around 620 nm. The ﬂuorescence intensity of mGluR1-AF594 increased after a photobleaching of A1R-AF647, while
the ﬂuorescence intensity of mGluR1-AF594 decreased after a photobleaching of Ctrl-AF647. Statistical signiﬁcance was tested using paired t-test. **, p < 0.01; ***, p < 0.001. (D)
Visualization of FRET in situ. The color bar represents FRET efﬁciency between AF594 and AF647 at individual pixels in photobleached areas marked by boxes. Scale bar, 10 mm. (E)
FRET efﬁciency between AF594 and AF647 at the plasma membrane. Statistical signiﬁcance was tested by one-way ANOVA, and differences among pairs were analyzed using
TukeyeKramer multiple comparison test. *, p < 0.05; ***, p < 0.001. Data are mean ± SEM.
Y. Kamikubo et al. / Journal of Pharmacological Sciences 128 (2015) 125e130128examined the effect of Gq activation on A1R signaling. In
HEK293am cells transiently expressing NK1R, an application of
1 mM SP, an NK1R agonist did not affect R-PIA-induced reduction
of [cAMP]i (97.7 ± 0.2% of SP-untreated cells, n ¼ 8). This result
suggests that the effect of mGluR1 on A1R signaling does not
require Gq.
Taken together, these results indicate that in HEK293am cells,
mGluR1modulates intracellular cAMP, not through its own cascade
or by directly activating adenylyl cyclase, but through functional
interaction with A1R.
4. Discussion
We have previously suggested the possibility that endogenous
A1R and mGluR1 form a functionally meaningful complex in
cerebellar Purkinje cells (15). In this study, we explored this com-
plex in greater detail using a cell line stably expressing both the
GPCRs. Co-immunoprecipitation and FRET experiments indicate
that this complex forms even in non-neuronal cells (Figs. 1 and 2).
Thus, the interaction is an intrinsic property of these receptors but
not a property conferred by the neuron-speciﬁc cellular environ-
ment. It is possible that this interaction is mediated by the
membrane-proximal C-terminal tail of A1R (15), which is folded
into an alpha-helical structure and contains four aromatic amino
acid residues aligned on one side (20).Based on previous studies, activated A1R modulates mGluR1
signaling in cultured neurons (12, 15, 21). However, whether
mGluR1 exhibited reciprocal effects on A1R was unclear. LANCE
cAMP data show that activated mGluR1 suppresses the ability of
A1R to inhibit cAMP production (Figs. 4e5). However, mGluR1 did
not obviously change basal [cAMP]i or forskolin-induced cAMP
production (Figs. 4e5). Therefore, mGluR1 appears to modulate
[cAMP]i by inhibiting A1R, not by activating adenylyl cyclase, in
contrast to some previous reports that mGluR1 may activate ade-
nylyl cyclase and protein kinase A in some cell types (22, 23).
mGluR1 induces cerebellar LTD, at synapses between cerebellar
parallel ﬁbers and Purkinje cells. In turn, cerebellar LTD is a form of
synaptic plasticity crucial for cerebellar motor learning (13, 14).
cAMP is an important messenger in many cellular processes,
including activation of cAMP response element-binding protein
(CREB), a transcription factor. CREB has a well-documented role in
synaptic plasticity and memory formation (24). Memory is thought
to be formed in two phases through synaptic plasticity. The early
phase depends on functional modiﬁcation of pre-existing proteins,
while the late phase requires transcription and de novo protein
synthesis, as well as CREB, at least in cultured Purkinje cells (25).
mGluR1-mediated inhibition of A1R signaling which is expected to
attenuate PKA and CREB activation, might have a regulatory role in
induction of mGluR1-dependent cerebellar LTD and its related
motor learning.
AB
C
Fig. 3. A1R activation inhibits forskolin-stimulated cAMP accumulation via Gi/Go.
(A) Treatment with 100 nM R-PIA, an A1R agonist, inhibits the increase in [cAMP]i due
to forskolin. Data were analyzed by two-way ANOVA, and differences between pairs
were analyzed using Bonferroni post tests. **, p < 0.01. Data points are mean ± SD. (B)
Treatment for >12 h with 500 ng/mL PTX, an inhibitor of Gi/Go, reverses the effect of R-
PIA on [cAMP]i. One-way ANOVA was used to test statistical signiﬁcance, and pairs
were compared using TukeyeKramer multiple comparison test. ns, p > 0.05; ***,
p < 0.001. (C) Treatment with 1 mMDPCPX, an A1R antagonist, reverses the effect of the
A1R agonist R-PIA. Statistical signiﬁcance was tested by one-way ANOVA, and pairwise
comparison was performed according to TukeyeKramer multiple comparison test. *,
p < 0.001 vs (c2); y, p < 0.001 vs (c3). Data are mean ± SD.
Fig. 4. mGluR1 activation impedes A1R signaling in HEK293am cells. (A) Treatment
with 100 mM DHPG, an mGluR1 agonist, suppresses the effect of R-PIA. Data were
analyzed by two-way ANOVA, and statistical signiﬁcance between pairs was tested
using Bonferroni post tests. *, p < 0.05; **, p < 0.01; ***, p < 0.001. Data points are
mean ± SD. (B) Effects of mGluR1 agonist and antagonist on A1R signaling. Forskolin
increases [cAMP]i, as indicated by a decrease in TR-FRET (b2). R-PIA suppresses for-
skolin action (b3). DHPG reverses this suppression (b4), while 50 mM CPCCOEt, a non-
competitive mGluR1 antagonist, inhibits the effect of DHPG (b5). Statistical signiﬁcance
was tested by one-way ANOVA, and pairs were compared using TukeyeKramer mul-
tiple comparison test. *, p < 0.05; **, p < 0.01; ***, p < 0.001 vs (b3); yyy, p < 0.001 vs
(b4). (C) CPCCOEt on its own does not affect basal [cAMP]i, and reverse forskolin action.
Statistical signiﬁcance was determined using unpaired t-test. ns, p > 0.05. Data are
mean ± SD.
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Fig. 5. mGluR1 activation affects [cAMP]i via A1R in HEK293am cells. (A) DHPG
reverses the effect of 100 nM R-PIA in a dose-dependent manner, starting at a dose of
10 mM. One-way ANOVA was used to test statistical signiﬁcance, and differences be-
tween pairs were analyzed using Dunnett multiple comparison test. *, p < 0.05; **,
p < 0.01; ***, p < 0.001 vs. cells treated with 1 mM forskolin and 100 nM R-PIA, but not
with DHPG. (B) DHPG by itself does not block forskolin stimulation of [cAMP]i (open
circle) and basal [cAMP]i (ﬁlled square). One-way ANOVA did not detect statistical
signiﬁcance (p > 0.05). Data points are mean ± SD.
Y. Kamikubo et al. / Journal of Pharmacological Sciences 128 (2015) 125e130130Our ﬁndings demonstrate that distinct neuronal GPCRs, each of
which plays a distinct role by itself, may assemble into a complex,
and cooperatively elicit intriguing and atypical cellular responses.
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